Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nimotuzumab”

150 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 150 results

Testing effectiveness (Phase 2)Ended earlyNCT01382745
What this trial is testing

Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers

Who this might be right for
Squamous Cell Carcinoma of Anal Canal
Dr. Te Vuong 1
Not applicableStudy completedNCT04949503
What this trial is testing

A Real-world Study of the Efficacy and Safety of Nimotuzumab in Combination With Chemoradiotherapy for LASCCHN

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Biotech Pharmaceutical Co., Ltd. 1,931
Testing effectiveness (Phase 2)Study completedNCT05278728
What this trial is testing

Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

Who this might be right for
Colorectal Cancer
Biotech Pharmaceutical Co., Ltd. 31
Testing effectiveness (Phase 2)WithdrawnNCT02041819
What this trial is testing

Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus

Who this might be right for
Squamous Cell Carcinoma of Esophagus
Zhejiang University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07354984
What this trial is testing

A Single-Arm Phase II Clinical Study of Docetaxel Combined With Nimotuzumab and Pucotenlimab as Second-Line and Beyond Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Sun Yat-sen University 30
Large-scale testing (Phase 3)Study completedNCT02395016
What this trial is testing

Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Biotech Pharmaceutical Co., Ltd. 90
Early research (Phase 1)UnknownNCT02395068
What this trial is testing

Pharmacokinetics Study of Nimotuzumab in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Biotech Pharmaceutical Co., Ltd. 40
Large-scale testing (Phase 3)Study completedNCT02083211
What this trial is testing

Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma

Who this might be right for
Cervical Cancer Recurrent or PersistentPalliative TreatmentMonoclonal Antibody in Cervical Cancer Treatment
National Institute of Cancerología 168
Testing effectiveness (Phase 2)UnknownNCT02858206
What this trial is testing

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

Who this might be right for
Esophageal Neoplasms
Chinese Academy of Medical Sciences 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT06771596
What this trial is testing

Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the Cervix

Who this might be right for
Uterine Cervical Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 43
Large-scale testing (Phase 3)UnknownNCT02611700
What this trial is testing

Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinomas
Biotech Pharmaceutical Co., Ltd. 504
Large-scale testing (Phase 3)UnknownNCT01402180
What this trial is testing

Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 128
Post-approval studies (Phase 4)UnknownNCT02945267
What this trial is testing

Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Unresectable Pancreatic Cancer
Chinese PLA General Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06429839
What this trial is testing

Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients

Who this might be right for
Esophageal CancerNimotuzumabChemoradiotherapy+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 55
Testing effectiveness (Phase 2)UnknownNCT01486992
What this trial is testing

MFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the Esophagus

Who this might be right for
Advanced Esophageal Carcinoma
Peking University 40
Large-scale testing (Phase 3)Looking for participantsNCT07445048
What this trial is testing

Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head & Neck Squamous Cell CarcinomaHead & Neck CancerPostoperative Adjuvant Treatment
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 370
Large-scale testing (Phase 3)Looking for participantsNCT05772208
What this trial is testing

Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 459
Not applicableStudy completedNCT00561873
What this trial is testing

Nimotuzumab in Children With HGG

Who this might be right for
High Grade Glioma
Oncoscience AG 45
Testing effectiveness (Phase 2)Study completedNCT01616849
What this trial is testing

Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Stage IV Nasopharyngeal Carcinoma
Sun Yat-sen University 39
Testing effectiveness (Phase 2)Study completedNCT04207918
What this trial is testing

A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer

Who this might be right for
Esophageal CancerChemoradiotherapyNimotuzumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 55
Load More Results